OUTCOME OF INTERSTITIAL LUNG DISEASE (ILD) IN ANTI-PM/SCL PATIENTS WITH SYSTEMIC SCLEROSIS: RESULTS FROM AN EUSTAR CASE-CONTROL STUDY.

被引：0
|
作者：
Lazzaroni, M. G. [1 ]
Campochiaro, C. [2 ,3 ,4 ]
Marasco, E. [5 ]
De Vries-Bouwstra, J. [6 ]
Franceschini, F. [1 ]
Del Galdo, F. [7 ]
Denton, C. [3 ,4 ]
Cavagna, L. [5 ]
Distler, O. [8 ]
Allanore, Y. [9 ,10 ]
Airo, P. [1 ]
机构：
[1] Univ Brescia, ASST Spedali Civili Brescia, Brescia, Italy
[2] Ist Sci San Raffaele, Milan, Italy
[3] Royal Free Hosp, London, England
[4] UCL, Med Sch, London, England
[5] Univ Pavia, Hosp IRCCS Policlin S Matteo Fdn Pavia, Pavia, Italy
[6] Leiden Univ Med Ctr LUMC, Leiden, Netherlands
[7] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[8] Univ Hosp Zurich, Zurich, Switzerland
[9] Univ Paris 05, Paris, France
[10] Cochin Hosp, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.4890
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0328
引用
收藏
页码：1105 / 1106
页数：2
相关论文
共 50 条
  • [21] Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center
    Bruni, Cosimo
    Praino, Emanuela
    Guiducci, Serena
    Bellando-Randone, Silvia
    Furst, Daniel E.
    Matucci-Cerinic, Marco
    JOINT BONE SPINE, 2017, 84 (06) : 747 - 748
  • [22] ANALYSIS OF CLINICAL-ANALYTICAL CHARACTERISTICS IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND INTERSTITIAL LUNG DISEASE (ILD): CASE-CONTROL STUDY
    Mena-Vazquez, N.
    Manrique-Arija, S.
    Romero-Barco, C.
    Urena-Garnica, I.
    Ordonez-Canizares, M.
    Jimenez-Nunez, F.
    Diaz-Cordoves, G.
    Rojas-Gimenez, M.
    Fuego, C.
    Caparros-Ruiz, R.
    Cano-Garcia, L.
    Belmonte, A.
    Irigoyen-Oyarzabal, M.
    Fernandez-Nebro, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 938 - 938
  • [23] Iressa and interstitial lung disease (ILD) in Japan - Lessons from a large nested case-control study to evaluate a safety issue
    Nyberg, Fredrik
    Hada, Shuji
    Rothman, Kenneth J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S287 - S288
  • [24] The Clinical Phenotype of Anti-Th/To plus Patients in Systemic Sclerosis: A Case-control Study Within the European Scleroderma Trials and Research (EUSTAR) Cohort
    Moschetti, Liala
    Pedretti, Eleonora
    Bonomi, Francesco
    Lopez, Maria Martin
    Cacciapaglia, Fabio
    Santos, Cristiana Sieiro
    Moroncini, Gianluca
    Allanore, Yannick
    Caetano, Joana
    Granel, Brigitte
    Groseanu, Laura
    De Santis, Maria
    Kuwana, Masataka
    Codullo, Veronica
    Silva, Mariana Pereira
    Bearzi, Pietro
    Belloli, Laura
    Taberner-Cortes, Alida
    Maglio, Cristina
    Del Galdo, Francesco
    Campochiaro, Corrado
    Truchetet, Marie-Elise
    Cuomo, Giovanna
    Parvu, Magda
    Iannone, Florenzo
    Carreira, Patricia
    Guiducci, Serena
    Franceschini, Franco
    Airo, Paolo
    Lazzaroni, Maria-Grazia
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4955 - 4958
  • [25] To study the treatment outcome in Indian systemic sclerosis patients with ILD-preliminary results from single centre
    Thabah, M. M.
    Torka, P.
    Deepanjali, S.
    Kaur, P.
    Sharma, S. K.
    Gupta, R.
    RHEUMATOLOGY, 2008, 47 : II86 - II86
  • [26] Toll interacting protein (TOLLIP) gene polymorphisms in patients with systemic sclerosis (SSc) associated interstitial lung disease (ILD): association with outcome and survival
    Schroeder, Niels
    Andrae, Jitka
    Knuth-Rehr, Diana
    Leja, Silke
    Hunzelmann, Nicolas
    Boerner, Eda
    Bonella, Francesco
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [27] Interstitial lung disease in Japanese patients with lung cancer - A cohort and nested case-control study
    Kudoh, Shoji
    Kato, Harubumi
    Nishiwaki, Yutaka
    Fukuoka, Masahiro
    Nakata, Kouichiro
    Ichinose, Yukito
    Tsuboi, Masahiro
    Yokota, Soichiro
    Nakagawa, Kazuhiko
    Suga, Moritaka
    Jiang, Haiyi
    Itoh, Yohji
    Armour, Alison
    Watkins, Claire
    Higenbottam, Tim
    Nyberg, Fredrik
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (12) : 1348 - 1357
  • [28] Toll Interacting Protein (TOLLIP) Gene Polymorphisms in Patients With Systemic Sclerosis (SSc) With and Without Interstitial Lung Disease (ILD): Association With Outcome and Survival
    Bonella, F.
    Schroeder, N.
    Knuth-Rehr, D.
    Leja, S.
    Moinzadeh, P.
    Hunzelmann, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [29] LONG-TERM OUTCOME OF A TARGETED TREATMENT REGIMEN WITH IV CYCLOPHOSPHAMIDE (CYC) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) AND INTERSTITIAL LUNG DISEASE (ILD)
    Ottewell, Lesley
    Walker, Karen
    Griffiths, Bridget
    RHEUMATOLOGY, 2009, 48 : I76 - I76
  • [30] NAILFOLD CAPILLAROSCOPY PATTERNS IN ADULTHOOD ARE SIMILAR IN PATIENTS WITH JUVENILE AND ADULT-ONSET SYSTEMIC SCLEROSIS: A EUSTAR CASE-CONTROL STUDY
    Ingegnoli, F.
    Boracchi, P.
    Gualtierotti, R.
    Smith, V.
    Cutolo, M.
    Foeldvari, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 154 - 155
12345